FDA 483 - Cure Pharmaceutical, Inc. - February 21, 2024

Cure Pharmaceutical, Inc. in Oxnard, CA was inspected by the FDA from February 20-21, 2024. The inspection revealed two significant issues related to quality control for dietary supplement manufacturing. Specifically, the firm failed to ensure components met established specifications and did not adequately qualify suppliers by confirming their certificates of analysis.